Cargando…
Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective)
OBJECTIVE: The aim of the study was to explore regulatory inspectors’ experiences with a new method for next-of-kin involvement in investigation of adverse events causing patient death. A resilient healthcare perspective is used as the theoretical foundation. METHODS: The study design was a qualitat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612908/ https://www.ncbi.nlm.nih.gov/pubmed/31651541 http://dx.doi.org/10.1097/PTS.0000000000000634 |
_version_ | 1784603537686134784 |
---|---|
author | Wiig, Siri Schibevaag, Lene Tvete Zachrisen, Rannveig Hannisdal, Einar Anderson, Janet E. Haraldseid-Driftland, Cecilie |
author_facet | Wiig, Siri Schibevaag, Lene Tvete Zachrisen, Rannveig Hannisdal, Einar Anderson, Janet E. Haraldseid-Driftland, Cecilie |
author_sort | Wiig, Siri |
collection | PubMed |
description | OBJECTIVE: The aim of the study was to explore regulatory inspectors’ experiences with a new method for next-of-kin involvement in investigation of adverse events causing patient death. A resilient healthcare perspective is used as the theoretical foundation. METHODS: The study design was a qualitative process evaluation of the new involvement method in 2 Norwegian counties. Next of kin, who had lost a close family member in an adverse event, were invited to a 2-hour face-to-face meeting with the inspectors. Data collection involved 3 focus group interviews with regulatory inspectors and observation (20 hours) of the meetings (2017–2018). Data were analyzed by a thematic content analysis. RESULTS: Next-of-kin involvement informed the investigations by additional and new information about the adverse events and by different versions of the investigators’ earlier obtained information, such as time sequences, what happened and how, and who were involved. Inspectors considered next of kin as a key source of information that contributed to improve the quality of the investigation. The downside was that the involvement method increased work load and could challenge the principle of equal treatment in regulatory practice. CONCLUSIONS: Involvement of next of kin in regulatory investigation of adverse events causing patient death contributes to a better understanding of work as done in clinical practice and contributes to strengthen the learning potential in resilience. |
format | Online Article Text |
id | pubmed-8612908 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-86129082021-11-29 Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective) Wiig, Siri Schibevaag, Lene Tvete Zachrisen, Rannveig Hannisdal, Einar Anderson, Janet E. Haraldseid-Driftland, Cecilie J Patient Saf Original Studies OBJECTIVE: The aim of the study was to explore regulatory inspectors’ experiences with a new method for next-of-kin involvement in investigation of adverse events causing patient death. A resilient healthcare perspective is used as the theoretical foundation. METHODS: The study design was a qualitative process evaluation of the new involvement method in 2 Norwegian counties. Next of kin, who had lost a close family member in an adverse event, were invited to a 2-hour face-to-face meeting with the inspectors. Data collection involved 3 focus group interviews with regulatory inspectors and observation (20 hours) of the meetings (2017–2018). Data were analyzed by a thematic content analysis. RESULTS: Next-of-kin involvement informed the investigations by additional and new information about the adverse events and by different versions of the investigators’ earlier obtained information, such as time sequences, what happened and how, and who were involved. Inspectors considered next of kin as a key source of information that contributed to improve the quality of the investigation. The downside was that the involvement method increased work load and could challenge the principle of equal treatment in regulatory practice. CONCLUSIONS: Involvement of next of kin in regulatory investigation of adverse events causing patient death contributes to a better understanding of work as done in clinical practice and contributes to strengthen the learning potential in resilience. Lippincott Williams & Wilkins 2021-12 2019-10-24 /pmc/articles/PMC8612908/ /pubmed/31651541 http://dx.doi.org/10.1097/PTS.0000000000000634 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Original Studies Wiig, Siri Schibevaag, Lene Tvete Zachrisen, Rannveig Hannisdal, Einar Anderson, Janet E. Haraldseid-Driftland, Cecilie Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective) |
title | Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective) |
title_full | Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective) |
title_fullStr | Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective) |
title_full_unstemmed | Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective) |
title_short | Next-of-Kin Involvement in Regulatory Investigations of Adverse Events That Caused Patient Death: A Process Evaluation (Part II: The Inspectors’ Perspective) |
title_sort | next-of-kin involvement in regulatory investigations of adverse events that caused patient death: a process evaluation (part ii: the inspectors’ perspective) |
topic | Original Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612908/ https://www.ncbi.nlm.nih.gov/pubmed/31651541 http://dx.doi.org/10.1097/PTS.0000000000000634 |
work_keys_str_mv | AT wiigsiri nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartiitheinspectorsperspective AT schibevaaglene nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartiitheinspectorsperspective AT tvetezachrisenrannveig nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartiitheinspectorsperspective AT hannisdaleinar nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartiitheinspectorsperspective AT andersonjanete nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartiitheinspectorsperspective AT haraldseiddriftlandcecilie nextofkininvolvementinregulatoryinvestigationsofadverseeventsthatcausedpatientdeathaprocessevaluationpartiitheinspectorsperspective |